ValuationViz

TEVA fund manager activity

Teva Pharmaceutical Industries Limited · NYSE. Reported by 18 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalAdded120,000$3,745,2000.01%Feb 17, 2026
Stanley Druckenmiller - Duquesne Family OfficeTrimmed5,874,870$183,355,0004.34%Feb 17, 2026
David Einhorn - Greenlight CapitalTrimmed3,058,734$95,463,0883.35%Feb 17, 2026
Lee Ainslie - Maverick CapitalSold out——0.00%Feb 13, 2026
Harry Burn - Sound ShoreTrimmed4,309,906$134,512,1664.28%Feb 10, 2026
Viking Global InvestorsSold out——0.00%Feb 17, 2026

Q3 2025

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalAdded110,000$2,222,0000.01%Nov 14, 2025
Stanley Druckenmiller - Duquesne Family OfficeAdded16,593,935$335,197,0008.53%Nov 14, 2025
Jeremy Grantham - GMOSold out——0.00%Nov 13, 2025
David Einhorn - Greenlight CapitalNo change3,778,777$76,331,2953.00%Nov 14, 2025
Lee Ainslie - Maverick CapitalTrimmed4,300,520$86,870,5041.16%Nov 14, 2025
Harry Burn - Sound ShoreTrimmed5,647,449$114,078,4703.77%Nov 6, 2025
Viking Global InvestorsTrimmed2,532,119$51,148,8040.13%Nov 14, 2025

Newer quarters · Older quarters